Home » Business, Health & Medicine, Marketing & Sales, Pharmaceuticals & Biotech » Cancer Generics Market: Industry Trends, Growth, Manufacturing Process, Machinery Requirements, Incomes and Profits
“Generic Oncology Drug Manufacturing Plant Project Report”
This report provides an insight into the cancer generics market and the requirements to setup and run a cancer generic manufacturing plant (both tablets and injectables). Factors such as capital cost, raw material requirements, machinery requirements, incomes, expenditures, etc. Have been thoroughly analysed in this report

This report explores the cancer generics market and provides the know-how to start and run a cancer generic drug manufacturing plant. The report finds that cancer generics have a higher entry barrier and product differentiation compared to conventional generics. This has resulted in a lower competitive intensityenabling them to be priced higher with substantially bigger margins.

IMARC’s latest study “Generic Oncology Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.

Key Questions Answered in This Report?

  • What is the key success and risk factors in the generic oncology drug industry?
  • How has the global generic oncology drugmarket performed so far and how will it perform in the coming years?
  • What is the structure of the generic industry and who are the key players?
  • What are the various unit operations involved in a generic oncology drug manufacturing plant?
  • What is the total size of land required for setting up a generic oncology drug manufacturing plant?
  • What are the machinery requirements for setting up a generic oncology drug manufacturingplant?
  • What are the raw material requirements for setting up a generic oncology drug manufacturingplant?
  • What are the utility requirements for setting up a generic oncology drug manufacturingplant?
  • What are the manpower requirements for setting up a generic oncology drug manufacturingplant?
  • What are the infrastructure costs for setting up a generic oncology drug manufacturingplant?
  • What are the capital costs for setting up a generic oncology drug manufacturingplant?
  • What are the operating costs for setting up a generic oncology drug manufacturingplant?
  • What will be the income and expenditures for a generic oncology drug manufacturingplant?
  • What is the time required to break-even?

Table of Contents

1 Research Methodology

2 Report Summary

3 Introduction

4 Global Generic Drug Market

4.1 Classification of Generic Drugs

4.2 Market Trends

4.2.1 Current and Historical Market Trends

4.2.2 Market Breakup by Region

4.2.3 Major Players in the Generic Drug Industry

4.2.4 Market Forecast

4.3 Value Chain Analysis of Generic Drugs

4.4 Key Success Factors Driving the Generic Drug Industry

4.6 Regulations in the Generic Drug Industry

5 Global Cancer Generics Market

5.1 Global Cancer Statistics

5.2 Current and Historical Market Trends

5.3 Top Cancer Drugs

5.4 Top Players in the Cancer Generics Market

5.5 Market Forecast

6 Manufacturing Process

6.1 Detailed Process Flow (Tablet)

6.2 Detailed Process Flow (Injectables)

6.3 Cancer Generic Manufacturing Plant: Raw Material Requirements

6.3.1 Cancer Generic Drug (Tablet)

6.3.2 Cancer Generic Drug (Injectables)

7 Project Details, Requirements and Costs Involved

7.1 Land, Location and Site Development

7.2 Plant Machinery

7.3 Machinery Pictures

7.4 Raw Materials

7.5 Packaging

7.6 Utilities

7.7 Manpower

7.8 Other Capital Investments

8 Cancer Generic Drug Manufacturing Plant: Project Economics

8.1 Capital Cost of the Project

8.2 Loans and Financial Assistance

8.3 Techno-Economic Parameters

8.4 Product Pricing

8.5 Income Projections

8.6 Expenditure Projections

8.7 Financial Analysis


List of Figures

Figure 1 1: Global: Cancer Incidence: Breakup by Country (in %), 2014

Figure 4 1: Global: Generics Market: Sales Value (in US$ Billion), 2010-2014

Figure 4 2: Global: Generics Market: Breakup by Country (in %), 2014

Figure 4 3: Global: Generics Market: Sales Value (in US$ Billion), 2015-2020

Figure 4 4: Global: Generics Market: Value Chain

Figure 5 1: Global: Cancer Incidence: 2007-2014

Figure 5 2: Global: Cancer Incidence: Breakup by Country (in %), 2014

Figure 5 3: Global: Cancer GenericsMarket: Sales Value (in US$ Billion), 2007-2014

Figure 5 4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020

Figure 6 1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow

Figure 6 2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow

Figure 6 3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks

Figure 6 4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks

Figure 7 1: Cancer Generic Manufacturing Plant: Primary Packaging

Figure 7 2: Cancer Generic Manufacturing Plant: Secondary Packaging

Figure 7 3: Cancer Generic Manufacturing Plant: Tertiary Packaging

Figure 8 1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)

Figure 8 2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)


List of Tables

Table 4 1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2014

Table 7 1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)

Table 7 2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)

Table 7 3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)

Table 7 4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)

Table 7 5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)

Table 7 6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)

Table 8 1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)

Table 8 2: Details of Financial Assistance Offered by Financial Institutions

Table 8 3: Cancer Generic Manufacturing Plant: Loan Installments

Table 8 4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters

Table 8 5: Cancer Generic Manufacturing Plant: Income Projections (in US$)

Table 8 6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)

Table 8 7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability

Table 8 8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099

IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/generic-oncology-drug-manufacturing-plant


About IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.


To know more about our company, please visit:
http://www.imarcgroup.com/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.